GSK3-inhibitor IX (BIO): Difference between revisions
Jump to navigation
Jump to search
imported>Xenbase |
imported>KABurns No edit summary |
||
| (2 intermediate revisions by one other user not shown) | |||
| Line 15: | Line 15: | ||
==References== | ==References== | ||
*[https://pubchem.ncbi.nlm.nih.gov/compound/5287844 NCBI PubChem CID:5287844] | *[https://pubchem.ncbi.nlm.nih.gov/compound/5287844 NCBI PubChem CID:5287844] | ||
*[http://www.xenbase.org/literature/article.do? | *[http://www.xenbase.org/literature/article.do?method=display&articleId=53106 Stevens et al., 2017] | ||
*[http://www.xenbase.org/literature/article.do?method=display&articleId= | *[http://www.xenbase.org/literature/article.do?method=display&articleId=52384 Maj et al., 2016] | ||
> 102 Xenbase articles contain a reference to GSK3-inhibitor IX according to [http://www.xenbase.org/cgi-bin/textpresso/xenopus/search textpresso] | |||
*[[Small Molecules for Xenopus Research|Back To Small Molecules Home Page]] | *[[Small Molecules for Xenopus Research|Back To Small Molecules Home Page]] | ||
Latest revision as of 12:15, 12 February 2018
Description
GSK3-inhibitor IX a reversible and ATP-competitive inhibitor of GSK-3α/β that functions as a WNT pathway activator.
Alternative names
- BIO
- 6BIO
- 6-bromoindirubin-3-oxime
Suppliers
Usage Notes
References
> 102 Xenbase articles contain a reference to GSK3-inhibitor IX according to textpresso